US Map / Mississippi
State MS

Clinical Trials in Mississippi

Recruiting clinical trials with at least one study location in Mississippi. Data updated daily from ClinicalTrials.gov.

Total Trials
58
Recruiting Now
58
← Back to US Map
Top Conditions in Mississippi
Malignant Solid Neoplasm (3)Lung Non-Small Cell Carcinoma (2)Breast Carcinoma (1)Colorectal Carcinoma (1)Melanoma (1)Non-Hodgkin Lymphoma (1)Adrenal Gland Pheochromocytoma (1)Carcinoma In Situ (1)Central Nervous System Neoplasm (1)Childhood Immature Teratoma (1)Childhood Kidney Neoplasm (1)Childhood Langerhans Cell Histiocytosis (1)
NCT07265479 Phase 3
Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participant...
Condition
Atopic Dermatitis
Enrollment
180 pts
Location
United States, Canada
Sponsor
Organon and Co
View Trial →
NCT06907147 N/A
Recruiting
SPYRAL GEMINI Pilot Study
Condition
Hypertension
Enrollment
175 pts
Location
United States, Australia, Greece
Sponsor
Medtronic Vascular
View Trial →
NCT05543616 Phase 2, Phase 3
Recruiting
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Heal...
Condition
SARS-CoV-2 Virus
Enrollment
4,292 pts
Location
United States, Brazil, Puerto Rico
Sponsor
BioNTech SE
View Trial →
NCT06667076 Phase 2
Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combina...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
480 pts
Location
United States, Belgium, Finland
Sponsor
Janssen Research & Development
View Trial →
NCT06904274 Phase 3
Recruiting
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Condition
Endometrial Hyperplasia
Enrollment
207 pts
Location
United States, Canada, China
Sponsor
Bayer
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT01719055 N/A
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-T...
Condition
Pain
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
Boston Scientific Corporation
View Trial →
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
Page 3 of 3 — 58 trials total
← Prev